Código QR (código de barras bidimensional)

Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin<sup>®</sup>) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series

Registered pharmacological treatments are insufficiently effective for erectile dysfunction (ED) in around 30% of affected men. Intracavernosal injection (ICI) of ona- and abobotulinumtoxinA can reduce ED in insufficient responders. We aimed to assess the safety and effectiveness of incobotulinumtox...

ver descrição completa

Na minha lista:
Principais autores: Francois Giuliano, Pierre Denys, Charles Joussain
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-04-01
coleção:Toxins
Assuntos:
botulinum toxin A
combination therapy
non-responders
erectile dysfunction
pharmacology
Acesso em linha:https://www.mdpi.com/2072-6651/14/4/286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados